Vimarsana
Biggest News Aggregation in the World

Page 41 - Ubsidiary News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Ubsidiary. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Ubsidiary Today - Breaking & Trending Today

Avangrid Chairman Ignacio Galán Receives the ESG Leadership Award from The Foreign Policy Association in New York - Vimarsana News

Avangrid Chairman Ignacio Galán Receives the ESG Leadership Award from The Foreign Policy Association in New York

Ignacio Galán, the Executive Chairman of Iberdrola, and Chairman of its U.S. subsidiary Avangrid, Inc. , has become the inaugural recipient of The Foreign Policy Association’s ESG... | May 25, 2023

Foothill Transit Orders 19 ENC Zero-Emission Axess® EVO-FC™ Hydrogen Fuel Cell Buses - Vimarsana News

Foothill Transit Orders 19 ENC Zero-Emission Axess® EVO-FC™ Hydrogen Fuel Cell Buses

ElDorado National or ENC, a subsidiary of REV Group, Inc., and an industry leader in heavy-duty transit buses and emission-free technology, secured an order for 19 Axess EVO-FC hydrogen fuel cell... | May 25, 2023

Veltex Corporation Shareholder Update - Vimarsana News

Veltex Corporation Shareholder Update

CHICAGO, May 25, 2023 /PRNewswire/ -- Veltex Corporation , a Health and Wellness Acquisition Firm, and its wholly owned subsidiary Veltex Medical, Inc. d/b/a Veltex Recovery Group , is pleased to... | May 25, 2023

The Menarini Group and its subsidiary Stemline Therapeutics: Menarini Group Shares New Analysis from EMERALD Clinical Study of ORSERDU (Elacestrant) in Metastatic Breast Cancer at ASCO 2023 - Vimarsana News

The Menarini Group and its subsidiary Stemline Therapeutics: Menarini Group Shares New Analysis from EMERALD Clinical Study of ORSERDU (Elacestrant) in Metastatic Breast Cancer at ASCO 2023

ORSERDU (elacestrant) was approved by the FDA in January 2023 for estrogen receptor (ER)-positive, human epidermal growth factor receptor 2 (HER2)-negative advanced or metastatic breast cancer with

EQUUS TOTAL RETURN, INC. : Entry into a Material Definitive Agreement, Completion of Acquisition or Disposition of Assets, Other Events, Financial Statements and Exhibits (form 8-K) - Vimarsana News

EQUUS TOTAL RETURN, INC. : Entry into a Material Definitive Agreement, Completion of Acquisition or Disposition of Assets, Other Events, Financial Statements and Exhibits (form 8-K)

Item 1.01 Entry into a Material Definitive Agreement. On May 22, 2023, Morgan E&P, LLC , a wholly-owned subsidiary of Equus Total Return, Inc. entered into a material definitive Purchase and... | May 25, 2023